These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29653947)

  • 1. "Recent lessons learned in the management of acute exacerbation of idiopathic pulmonary fibrosis." Yasuhiro Kondoh, Vincent Cottin and Kevin K. Brown.
    Eur Respir Rev; 2018 Jun; 27(148):. PubMed ID: 29653947
    [No Abstract]   [Full Text] [Related]  

  • 2. "Long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis." Vincent Cottin and Toby Maher. Eur Respir Rev 2015; 24: 58-64.
    Eur Respir Rev; 2015 Sep; 24(137):545. PubMed ID: 26324819
    [No Abstract]   [Full Text] [Related]  

  • 3. "Idiopathic inflammatory myopathies and the lung." Jean-Christophe Lega, Quitterie Reynaud, Alexandre Belot, Nicole Fabien, Isabelle Durieu and Vincent Cottin. Eur Respir Rev 2015; 24: 216-238.
    Eur Respir Rev; 2015 Sep; 24(137):545. PubMed ID: 26324818
    [No Abstract]   [Full Text] [Related]  

  • 4. "Lung biopsy in interstitial lung disease: balancing the risk of surgery and diagnostic uncertainty." Vincent Cottin. Eur Respir J 2016; 48: 1274-1277.
    Eur Respir J; 2016 Dec; 48(6):1819. PubMed ID: 27903698
    [No Abstract]   [Full Text] [Related]  

  • 5. "Clinical phenotypes and outcomes of precapillary pulmonary hypertension of sickle cell disease." Laurent Savale, Anoosha Habibi, François Lionnet, Bernard Maitre, Vincent Cottin, Xavier Jais, Ari Chaouat, Elise Artaud-Macari, Matthieu Canuet, Grégoire Prevot, Christelle Chantalat-Auger, David Montani, Olivier Sitbon, Fréderic Galacteros, Gérald Simonneau, Florence Parent, Pablo Bartolucci and Marc Humbert.
    Eur Respir J; 2020 Jan; 55(1):. PubMed ID: 32001502
    [No Abstract]   [Full Text] [Related]  

  • 6. "Characterisation of patients with interstitial pneumonia with autoimmune features." Justin M. Oldham, Ayodeji Adegunsoye, Eleanor Valenzi, Cathryn Lee, Leah Witt, Lena Chen, Aliya N. Husain, Steven Montner, Jonathan H. Chung, Vincent Cottin, Aryeh Fischer, Imre Noth, Rekha Vij and Mary E. Strek.
    Eur Respir J; 2017 May; 49(5):. PubMed ID: 28495685
    [No Abstract]   [Full Text] [Related]  

  • 7. "Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis." Kevin R. Flaherty, Charlene D. Fell, J. Terrill Huggins, Hilario Nunes, Robert Sussman, Claudia Valenzuela, Ute Petzinger, John L. Stauffer, Frank Gilberg, Monica Bengus and Marlies Wijsenbeek.
    Eur Respir J; 2018 Oct; 52(4):. PubMed ID: 30287496
    [No Abstract]   [Full Text] [Related]  

  • 8. "Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis." Bridget F. Collins and Ganesh Raghu.
    Eur Respir Rev; 2019 Dec; 28(154):. PubMed ID: 31722893
    [No Abstract]   [Full Text] [Related]  

  • 9. "The therapy of idiopathic pulmonary fibrosis: what is next?" Vivien Somogyi, Nazia Chaudhuri, Sebastiano Emanuele Torrisi,
    Eur Respir Rev; 2019 Sep; 28(153):. PubMed ID: 31554706
    [No Abstract]   [Full Text] [Related]  

  • 10. "Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis." M. Kolb, B. Crestani and T.M. Maher.
    Eur Respir Rev; 2024 Jan; 33(171):. PubMed ID: 38537950
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report.
    Collard HR; Ryerson CJ; Corte TJ; Jenkins G; Kondoh Y; Lederer DJ; Lee JS; Maher TM; Wells AU; Antoniou KM; Behr J; Brown KK; Cottin V; Flaherty KR; Fukuoka J; Hansell DM; Johkoh T; Kaminski N; Kim DS; Kolb M; Lynch DA; Myers JL; Raghu G; Richeldi L; Taniguchi H; Martinez FJ
    Am J Respir Crit Care Med; 2016 Aug; 194(3):265-75. PubMed ID: 27299520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Recent advances in targeting the prostacyclin pathway in pulmonary arterial hypertension." Irene M. Lang and Sean P. Gaine. Eur Respir Rev 2015; 24: 630-641.
    Eur Respir Rev; 2016 Mar; 25(139):99. PubMed ID: 26929428
    [No Abstract]   [Full Text] [Related]  

  • 13. "Recent advances in targeting the prostacyclin pathway in pulmonary arterial hypertension." Irene M. Lang, Sean P. Gaine. Eur Respir Rev 2015; 24: 630-641.
    Eur Respir Rev; 2017 Jan; 26(143):. PubMed ID: 28049123
    [No Abstract]   [Full Text] [Related]  

  • 14. Viral infection in acute exacerbation of idiopathic pulmonary fibrosis.
    Wootton SC; Kim DS; Kondoh Y; Chen E; Lee JS; Song JW; Huh JW; Taniguchi H; Chiu C; Boushey H; Lancaster LH; Wolters PJ; DeRisi J; Ganem D; Collard HR
    Am J Respir Crit Care Med; 2011 Jun; 183(12):1698-702. PubMed ID: 21471095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute exacerbation of idiopathic pulmonary fibrosis: lessons learned from acute respiratory distress syndrome?
    Marchioni A; Tonelli R; Ball L; Fantini R; Castaniere I; Cerri S; Luppi F; Malerba M; Pelosi P; Clini E
    Crit Care; 2018 Mar; 22(1):80. PubMed ID: 29566734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosis." Nikhil Hirani, Alison C. MacKinnon, Lisa Nicol,
    Eur Respir J; 2022 Apr; 59(4):. PubMed ID: 35422427
    [No Abstract]   [Full Text] [Related]  

  • 17. Danger-associated molecular patterns and danger signals in idiopathic pulmonary fibrosis.
    Ellson CD; Dunmore R; Hogaboam CM; Sleeman MA; Murray LA
    Am J Respir Cell Mol Biol; 2014 Aug; 51(2):163-8. PubMed ID: 24749648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute exacerbations of interstitial lung disease: lessons from idiopathic pulmonary fibrosis.
    Spagnolo P; Wuyts W
    Curr Opin Pulm Med; 2017 Sep; 23(5):411-417. PubMed ID: 28582317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Design of pulmonary rehabilitation programmes during acute exacerbations of COPD: a systematic review and network meta-analysis." Ana Machado, Pedro Matos Silva, Vera Afreixo, Cátia Caneiras, Chris Burtin and Alda Marques.
    Eur Respir Rev; 2021 Mar; 30(159):. PubMed ID: 33568528
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk factors for an acute exacerbation of idiopathic pulmonary fibrosis.
    Kakugawa T; Sakamoto N; Sato S; Yura H; Harada T; Nakashima S; Hara A; Oda K; Ishimoto H; Yatera K; Ishimatsu Y; Obase Y; Kohno S; Mukae H
    Respir Res; 2016 Jul; 17(1):79. PubMed ID: 27401332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.